share_log

Coya Therapeutics | 8-K: Coya Therapeutics Provides a Corporate Update and Reports Unaudited Second Quarter 2024 Financial Results

SEC ·  Aug 12 08:05
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more